Search

Search Results
Results 581 - 590 of 1413 for Active treatment
  • Alphaclav Duo Viatris 500/125 and Alphaclav Duo Forte Viatris 875/125
    Drug - 8 Oct 2024
    Consumer Medicine Information (CMI) about Alphaclav Duo Viatris 500/125 and Alphaclav Duo Forte Viatris 875/125 intended for persons living in Australia.
  • Methylphenidate-Teva XR
    Drug - 4 Oct 2024
    Consumer Medicine Information (CMI) about Methylphenidate-Teva XR intended for persons living in Australia.
  • Deptran
    Drug - 4 Oct 2024
    Consumer Medicine Information (CMI) about Deptran intended for persons living in Australia.
  • Neo-Synephrine
    Drug - 30 Sep 2024
    Consumer Medicine Information (CMI) about Neo-Synephrine intended for persons living in Australia.
  • Antenex
    Drug - 18 Sep 2024
    Consumer Medicine Information (CMI) about Antenex intended for persons living in Australia.
  • Orencia
    Drug - 29 Aug 2024
    Consumer Medicine Information (CMI) about Orencia intended for persons living in Australia.
  • Lavione
    Drug - 21 Aug 2024
    Consumer Medicine Information (CMI) about Lavione intended for persons living in Australia.
  • Betadine Antiseptic Topical Ointment
    Drug - 16 Aug 2024
    Consumer Medicine Information (CMI) about Betadine Antiseptic Topical Ointment intended for persons living in Australia.
  • Betadine Sore Throat Gargle
    Drug - 16 Aug 2024
    Consumer Medicine Information (CMI) about Betadine Sore Throat Gargle intended for persons living in Australia.
  • Betadine Antiseptic Liquid Spray
    Drug - 16 Aug 2024
    Consumer Medicine Information (CMI) about Betadine Antiseptic Liquid Spray intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback